Simultaneous PET/MR imaging has been successfully implemented for whole-body staging of numerous tumor entities within the last four years. However, to date, the introduced study protocols were acquainted with prolonged examination times, potentially impeding patient comfort and patient compliance. The present results demonstrate the high diagnostic capability of integrated PET/MR imaging for staging patients with suspected breast cancer recurrence. Furthermore, facing the need for an optimization of dedicated MR study protocols for whole-body PET/MR imaging on oncological purposes, the present data support the application of fast, yet morphologically adequate PET/MR protocols, leaving the application of contrast-agent and DWI debatable.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords